Where the stock stands
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) is a Healthcare sector name, and the pack carries no other detail about the business, so this page sticks to the market data. The stock last traded at 8597.0, down 1.75% from the previous close of 8750.5, while the Nifty was down 0.15% - so the fall was largely stock-specific rather than market-wide.
Longer windows show a climb that has stalled. The pack has the stock up 21.71% over a year and 7.77% over three months, but 0.36% lower over a month and 3.30% lower over the past week. On valuation it records a price-to-earnings ratio of 64.83, a price-to-book of 12.99, a return on equity of 21.5% and a dividend yield of 0.23% - a rich multiple sitting alongside a high return on equity.
What the smart-money flow shows
The only positioning signal in the pack comes from the futures market, and it is labelled a short buildup: open interest rose 3.64% while the price fell 1.45%. A short buildup means fresh futures contracts were opened as the price declined, pointing to new bearish positions rather than existing bulls squaring off. The 1.45% change attached to that record does not match the cash-market change of 1.75%; the two are stamped at different moments, so the futures figure is its own snapshot.
That is where the flow evidence stops, and the gap matters for a stock this heavily traded. The pack carries no bulk or block deal records, no named institutional buyer or seller, no run of consecutive FII or DII buying, and no insider or promoter filings. That is an absence in this dataset rather than proof nothing happened - but it does mean the whole positioning read rests on one aggregate open-interest print, with no way to see who sits on which side of it.
The technical picture
A conflict to flag first: the technical block is stamped to 2026-08-11 at a close of 8750.5, which is the previous close in the price block, so every reading here predates the latest session's fall. On that earlier stamp the 14-day RSI stood at 45.4 - under the 50 midpoint, but at neither the overbought nor the oversold extreme - and relative volume was 2.16, more than twice the usual pace.
On the same date the price sat above both the 50-day and the 200-day moving average, with neither a golden cross nor a death cross flagged. The 52-week range runs from 6696.5 to 9050.0, and the pack places the stock 3.31% below its high and 30.67% above its low - figures that also belong to the earlier close, so the real distance from the high is wider than the recorded 3.31%.
Catalysts and what to watch
The pack lists results dated 2026-08-12 with a consensus earnings-per-share estimate of 38.30. A NiftyTrader headline four days ago flagged that Q1 FY27 print, pointing to a HealthCo breakeven and a demerger update as the focus. The pack also holds five NSE disclosures between 24 and 28 June 2026, each an intimation about a Scheme of Arrangement classified as a demerger or spin-off; they are tagged bullish, but only the fact of the intimation is recorded, not its terms.
Moneycontrol reported a day ago that this stock and Max Healthcare each slipped about 1% after a Parliamentary panel recommendation involving a three-star cap on rooms; that headline is truncated in the pack, so what was capped is not recorded. Reuters reported a sector listing: Manipal Health's debut jumped 10.5% at a $9 billion valuation after an oversubscribed IPO.
What the data establishes is narrow: a stock-specific down day against a flat index, short buildup in the futures book, technical readings that lag the latest close, a scheme of arrangement disclosed in June, and a results date on the calendar. It does not establish why the stock fell, whether institutions were involved, or what the scheme contains.